Abstract
This study investigated the ability of rhodococci to biodegrade diclofenac (DCF), one of the polycyclic non-steroidal anti-inflammatory drugs (NSAIDs) most frequently detected in the environment. Rhodococcus ruber strain IEGM 346 capable of complete DCF biodegradation (50âµg/L) over 6 days was selected. It is distinguished by the ability to degrade DCF at high (50âmg/L) concentrations unlike other known biodegraders. The DCF decomposition process was accelerated by adding glucose and due to short-term cell adaptation to 5âµg/L DCF. The most typical responses to DCF exposure observed were the changed ζ-potential of bacterial cells; increased cell hydrophobicity and total cell lipid content; multi-cellular conglomerates formed; and the changed surface-to-volume ratio. The obtained findings are considered as mechanisms of rhodococcal adaptation and hence their increased resistance to toxic effects of this pharmaceutical pollutant. The proposed pathways of bacterial DCF metabolisation were described. The data confirming the C-N bond cleavage and aromatic ring opening in the DCF structure were obtained.
Similar content being viewed by others
Introduction
In recent years, there is a growing interest to study the bioavilability and toxic effects of pharmaceutical pollutants on environmental microorganisms, which act as primary response systems and trigger the adaptive reactions. The present study relies on the assumption that members of the genus Rhodococcus could play important ecological roles in biological detoxification and decontamination of soils and water. They are stable inhabitants of polluted soils, water bodies, activated sludge, and wastewater; they have high oxidoreductase activities, abundant adaptation abilities for various toxic compounds, and high bioremediation potential for contaminated environments1,2,3,4. The number of studies on the topical issue is increasing, that indicates the timeliness of exploiting the metabolic Rhodococcus capabilities to biodegrade pharmaceuticals5,6,7,8,9,10. We have previously demonstrated for rhodococci to completely biodegrade analgesic and antispasmodic drugs, including paracetamol11, drotaverine hydrochloride12,13. In the present study, an âexploratoryâ analysis of their possible role as key biooxidizers of pharmaceuticals from the group of non-steroidal anti-inflammatory drugs (NSAIDs) ubiquitously detected in the environment was in focus14,15.
One of such anthropogenic micropollutants is diclofenac (DCF), a phenylacetic acid derived NSAID widely available and used in the world human medicine and veterinary. The annual DCF consumption is expressed in hundreds of tons16. Actual concentrations of DCF frequently detected in ground water17,18, surface (including marine)19,20,21,22, sewage23,24,25,26,27 and even drinking28,29 waters range from 0.02âng/L to 20.00âμg/L worldwide. Along with non-metabolized DCF, its metabolites (4â²-hydroxy-DCF, 5-hydroxy-DCF and p-benzoquinone imine of 5-hydroxy-DCF) have been detected in sewage water and river sediments30,31.
Because the n-octanol/water partition coefficient (log Kow) for DCF is 4.5132, the lipophilicity of this chemical can contribute to its potential bioaccumulation in living organisms, and first of all in hydrobionts. The Hazard Quotient values for DCF detected in freshwater far exceed 1 (HQ 155.22)33. It indicates that this pharmaceutical substance is a source of adverse effects on natural environments (hydrobionts and humans)34. DCF is on the Watch List of substances of particular concern in the EU, and has been considered as a pharmaceutical of the greatest potential environmental risk35.
Application of traditional physicochemical technologies for removal of pharmaceutical pollutants from water/wastewater is eco-unsafe because it is limited by possible by-products of their degradation, and is fairly expensive due to high operational and energy costs36,37,38. In terms of efficiency, safety and economic criteria, the biotechnological ways of converting these environmental stressors are recognized as priority approaches.
However, studies on DCF bioconversion are still few and mainly focused on eukaryotic organisms, in particular basidiomycetes (Bjerkandera, Trametes, Phanerohaete), zigomycetes (Cunninghamella) and entomopathogenic (Beauveria) fungi39. The bacterial degradation of DCF is little understood, except for the previous occasional reports on DCF biotransformations by Gram-positive bacteria Actinoplanes40 and Brevibacterium41, as well as by microorganisms of activated sludge42,43,44. More recently, Moreira et al.45 reported for the first time the complete DCF degradation using an alphaproteobacterial strain Labrys portucalensis F11 in the presence of acetate and proposed possible metabolic pathways for DCF decomposition. Biodegradation of DCF at relatively high concentrations have been demonstrated using enterobacterial Klebsiella sp. and Enterobacter hormaechei46,47. Meanwhile, there is a clear lack of information on the mechanism and effectiveness of protective responses triggered in the bacterial cell exposed to this ecotoxicant.
The purpose of this study was to assess the resistance of actinobacteria of the genus Rhodococcus to DCF exposure and their capabilities for its bioconversion, to investigate the features of bacterial cell-pharmaceutical interactions. This study has investigated the patterns of DCF biodegradation in relation to physiological states and culture conditions of rhodococci, as well as their responses to adverse ecotoxicant effects. The metabolites formed in the degradation process have been detected and reactions of bacterial DCF degradation have been described. This is the first report on the ability of Rhodococcus representatives to degrade this ecotoxic compound.
Materials and Methods
Microorganisms
In this work, 104 rhodococcal strains from the Regional Specialised Collection of Alkanotrophic Microorganisms (IEGM, WDCM 768, http://www.iegmcol.ru) were used. They belonged to 10 Rhodococcus species: R. cercidiphylli (1 strain), R. corynebacterioides (2 strains), R. erythropolis (41 strains), R. jostii (3 strains), R. koreensis (1 strain), R. pyridinivorans (2 strains), R. qingshengii (4 strains), R. rhodochrous (8 strains), R. ruber (41 strains), and R. wratislaviensis (1 strain). The strains were selected by geography and isolation sources as well as by the known catalytic activities of rhodococci towards complex organic compounds48.
Chemicals
Diclofenac (C14H11Cl2NO2, CAS number 15307-86-5, 2-[2-(2,6-dichloroanilino)phenyl]acetic acid as the sodium salt) was used in the form of a pharmaceutical substance (white or light-beige crystalline odorless powder, 99.0% purity in terms of dry matter, sparingly soluble in water; Kairav Chemicals Ltd, India). Chemicals, including ibuprofen, meloxicam, acetonitrile and chloroform, were of chemical, analytical or extra-pure grades (Kryochrom, Russia; Merck, Germany; Sigma-Aldrich, USA). A Millipore Simplicity Personal Ultrapure Water System (Millipore, USA) was employed to obtain ultrapure water for high-performance liquid chromatography (HPLC).
Culture conditions
Mineral medium RS48 was used in DCF biodegradation experiments. The initial DCF concentrations (50âμg/L and 50âmg/L) were chosen with regard for the large amounts to be used, its release rate into the environment, and ecological persistence. The selection relied on the actual DCF concentrations detected in aquatic and soil environments, and on the assumption that large doses cause negative effects, but also stimulate the organismâs defense mechanisms, while small doses cause negative effects without stimulating the defenses. DCF was used as 0.1% water solution sterilized at 110â°C for 15âmin. Before inoculation, the initial pH of the medium was 7.0. Cells pre-grown in LB broth (Sigma-Aldrich, USA) for two days and washed twice with phosphate buffer (pH 7.0) were inoculated into the RS medium to the final concentration of 3.7âÃâ107 cells/mL. Rhodococci were pre-grown at a low (5âμg/L) DCF concentration. D-Glucose (0.5%) was used as a co-substrate. Biodegradation was carried out at 28â°C. To avoid DCF photooxidation, flasks were protected by light-proof material. Due to lengthy (more than 60 days) laboratory experiments, the obtained values were corrected for water evaporation using equations in Gauthier et al.5.
Controls
The controls were (i) mineral medium plus DCF (to assess the abiotic degradation of DCF); (ii) mineral medium with DCF plus rhodococci inactivated by threefold autoclaving at 120â°C for 20âmin (to evaluate DCF adsorption on bacterial cells); (iii) mineral medium plus glucose and living bacterial cells without DCF (to discriminate DCF decomposition metabolites).
Determination of the minimal inhibitory concentrations of DCF
The minimal inhibitory concentrations (MICs) of DCF for rhodococci were determined by a twofold dilution method49 in LB broth using standard 8âÃâ12 (96) polystyrene plates. DCF was added at the initial concentration of 200âmg/L to the first well in each row, followed by a twofold dilution. The resulting mixture was supplemented with 10âμL of the bacterial test culture (3âÃâ107 cells/mL) pre-grown in LB broth for 2 days. The bacteria were incubated at 28â°C for 3 days and stirred (300ârpm) on a Titramax 1000 plate shaker (Heidolph, Germany), followed by cell staining with 0.2% aqueous iodonitrotetrazolium chloride solution. To determine MICs for mixtures of DCF and other pharmaceuticals (particularly ibuprofen, meloxicam) most frequently detected in the environment, the test compounds were mixed in aliquots.
Microscopic examinations
Cells were visualized using an Axiostar plus optical microscope (Carl Zeiss, Germany) in a phase contrast mode. Images were captured with the Pixera PRO 150ES camera (Pixera, USA) and analyzed using VideoTesT-Size 5.0 (Akond, Russia). DCF effects on cell morphology and surface relief were examined by a combined atomic-force and confocal laser scanning system consisting of a MFP-3D-BIO⢠atomic force microscope (AFM, Asylum Research Inc., USA), and an Olympus Fluo View 1000 confocal laser microscope (CLSM, Olympus Corporation, Japan). To differentiate living and dead cells, the bacterial suspension was stained with LIVE/DEAD® BacLight⢠Bacterial Viability Kit (Invitrogen, USA). The root-mean-square roughness of the cell surface, cell length and width were determined, and the cell volume and surface area were calculated. The images were processed using the Igor Pro 6.22âA (WaveMetrics, USA).
Cell hydrophobicity
The degree of bacterial cell hydrophobicity was determined by the salt aggregation test method50. Rhodococci were suspended in a phosphate buffer supplemented with ammonium sulfate. The minimal concentration of (NH4)2SO4 solution, at which cell aggregates were formed, was taken as the conditional value of cell wall hydrophobicity. The degree of hydrophobicity was assessed according to the scale: high hydrophobicity corresponded to the salinity index of the ammonium sulfate solution ranging from 0 to 0.8âM; moderate â from 1.0 to 2.0âM; weak â from 2.2 to 3.8 M51.
Zeta potential measurements
Zeta potential of bacterial cells was measured by dynamic light scattering method using a ZetaSizer Nano ZS analyzer (Malvern Instruments, UK) with the Malvern ZetaSizer software, v. 2.2. Cells grown in the mineral medium plus DCF were washed twice and resuspended in 0.1âM KNO3 (pH 7.0) until OD600 was 0.2. Measurements were carried out in a U-shaped cuvette with gold-plated electrodes at 25â°C and pH 7.0.
Total lipid content
Total lipids were determined in comparative studies of 3-day LB-grown bacterial cells and 15-day cells grown in the mineral medium plus DCF. For this, 50âmg of dry cell biomass was aged for 24âh in 5âmL of the following mixture: distilled water (1âmL), chloroformâ+âmethanol (4âmL) in a volume ratio of 1:2. After 24âh, the mixture was centrifuged at 3,000ârpm for 10âmin. The supernatant was decanted into a centrifuge tube. The resulting precipitate was re-extracted with 5âmL of chloroform-methanol-water (1:2:0.8). The supernatant and the extract supplemented with 5âmL of chloroform-water (1:1) were combined and centrifuged. Aliquots of the chloroform layer were transferred into dry, pre-weighed round-bottomed flasks and diluted with an equivalent amount of benzene. The resulting mixture was evaporated on a rotary evaporator (Heidolph, Germany) at 60â°C to a constant weight. The total lipids were measured gravimetrically and the amount was expressed as percent of absolute dry weight (ADW).
Respiration measurements
Cell respiratory activity was measured with a 6-channel Micro-Oxymax® respirometer (Columbus Instruments, USA). The experiments were carried out in 300âmL Micro-Oxymax glass bottles with 100âmL of the mineral medium at constant stirring (300ârpm, 28â±â2â°C). The amounts (μL) and rates (μL/min) of O2 consumed and CO2 released were measured. The respiratory activity was automatically recorded every 42âmin for 5â10 days.
Analytical methods
DCF concentration was HPLC-measured using a LC Prominence chromatograph (Shimadzu, Japan) equipped with a Phenomenex Jupiter® 5âu reversed-phase C18 300, A column 250âÃâ4.6âmm, 5 micron (Phenomenex, USA), and a diode-matrix detector. Mobile phase: phosphate buffer (pH 3.5):acetonitrile (60:40, v/v). Elution mode was isocratic. Mobile phase flow rate was 1.0âmL/min. Detection wavelength was at 273ânm. Volume of the injected sample was 20âμL. Thermostat temperature was 40â°C. The DCF retention time was 18.7â±â0.02âmin. Samples for the analysis were centrifuged at 10,000ârpm for 5âmin. The supernatant was filtered through a 0.20âμm pore size membrane filter (Whatman, UK).
DCF degradation products were analyzed by gas chromatography-mass spectrometry (GC-MS) using an Agilent 6890â5973âN chromatograph (Agilent Technologies, USA) equipped with a HP-5MS capillary column (30âm; inner diameter, 0.25âmm) operating in the ionization mode with an electronic impact at 70âeV. Helium was the carrier gas (1âmL/min). Injector and interface temperatures were 260 and 290â°C, respectively. Column temperature: 130â°C/10â°C/min/300â°C. The chloroform extract (1âμL) was injected without separation of the carrier gas flow. The mass spectra were recorded in the range of 40â500âm/z. The resulting mass spectra were compared with NIST 98 Mass Spectral Library spectra with the Microsoft® Windows Search Program (Version 1.7). Mass spectra of the test substance were considered as identified when they were identical to library spectra by more than 90%. To isolate DCF and its possible metabolites, the culture medium was acidified with 10% aqueous HCl solution to pH 2.0 and extracted three times with an equal volume (10âmL) of chloroform. The combined extracts were dried over Na2SO4. The solvent was removed on a Laborota 4000 efficient rotary evaporator (Heidolph, Germany). Phenylacetic and fumaric acids were identified by thin layer chromatography (TLC) in the system of benzene:95% ethanol:glacial acetic acid (45:8:4, v/v/v) using Sorbfil plates (Russia). The infrared (IR) spectra of dry residues obtained after evaporation of the mixture of DCF biodegradation products were measured in KBr pellets on a SPECORD M-80 IR spectrophotometer (Carl Zeiss Jena, Germany).
Results
Rhodococci resistance to DCF
The great majority of the cultures tested retained their viability when exposed to DCF concentrations ranging from 50 to 80âmg/L. The dendrogram (Fig. 1) presents the clustering of bacterial strains according to DCF MICs. Rather few (18) strains resisted relatively high (MIC â¥200âmg/L) DCF concentrations. The most resistant appeared to be strains from ecologically important species R. erythropolis, R. rhodochrous and R. ruber. They were previously isolated mainly from municipal wastewater (R. erythropolis IEGM 211, IEGM 213, IEGM 250, IEGM 712; R. ruber IEGM 343, IEGM 346), spring water (R. erythropolis IEGM 199, IEGM 201; R. ruber IEGM 231, IEGM 237) and groundwater (R. ruber IEGM 341, IEGM 342, IEGM 369).
According to the published data, DCF MIC values for pathogenic and opportunistic strains of Escherichia coli C600 and Staphylococcus aureus 6571 were 50â100âmg/L52, Enterococcus faecalis â50âmg/L53, Mycobacterium spp. â10â25âmg/L54. Our results indicate that environmentally isolated Rhodococcus strains resisted higher (MIC â¥200âmg/L) DCF concentrations.
The least (MIC 25â50âmg/L) DCF resistant strains were isolated from surface water (R. erythropolis IEGM 700; R. pyridinivorans IEGM 1277; R. ruber IEGM 86, IEGM 90, IEGM 91, IEGM 222), well water (R. erythropolis IEGM 200, IEGM 203; R. ruber IEGM 351, IEGM 352, IEGM 380, IEGM 384), mineral water (R. erythropolis IEGM 496; R. ruber IEGM 320, IEGM 321), soil (R. cercidiphylli IEGM 1184; R. corynebacterioides IEGM 931, IEGM 1202; R. jostii IEGM 68; R. wratislaviensis IEGM 1171), and snow (R. rhodochrous IEGM 639; R. ruber IEGM 442, IEGM 451).
In aquatic ecosystems, a mixture of pharmaceuticals from different therapeutic groups, including NSAIDs, is usually found17,19,21,23. Analysis of DCF mixed with ibuprofen and meloxicam showed that the cocktail of these substances (even at lower concentrations) had a greater inhibitory effect on R. ruber IEGM 346 cells than each compound separately. According to our data, DCF MIC value was 200âmg/L, while it decreased eightfold (to 25âmg/L) in a mixture with ibuprofen and meloxicam (Table 1). The obtained findings are consistent with other studies reporting that a pharmaceutical cocktail at lower concentrations causes greater ecotoxicological damage than individual compounds32.
To study DCF as a metabolic factor in rhodococci, R. ruber IEGM 346 (GenBank KF155234) was selected. It is characterized by pronounced emulsifying and biodegrading abilities for individual hydrocarbons and petroleum products, and by its resistance to Cu2+, Mo6+ and Pb2+ (5.0âmM). Additionally, this strain exhibits stable activity in extreme acidity (pH 2â6) and salinity (2â6% NaCl) of the medium48.
DCF biodegradation by R. ruber IEGM 346
DCF decomposition in a high (50âmg/L) concentration progressed slowly, indicating the high chemical stability of the parent ecotoxicant molecule (Fig. 2a). The residual DCF in the post-fermentation medium of strain IEGM 346 was yet about 50% on day 60. The average rate of DCF biodegradation was 0.4âmg per day throughout the experiment. The maximum (0.7âmg per day) biodegradation rate was observed during the first 10 experimental days. The maximum specific rate of DCF degradation (mg DCF/mg CDW per day) was 0.02âdayâ1. On day 10, an increased rhodococcal growth and a gradual decrease in DCF concentration were recorded under condition of fractional feeding with glucose as an easily utilized carbon source. Measurable abiotic degradation of DCF ranged from 2 to 5%. The control with inactivated cells (Fig. 2) showed an insignificant (up to 10%) decrease in the initial DCF concentration, indicating a possible partial sorption of the compound on the bacterial cell surface.
For low (50âμg/L) DCF concentration, the situation was different. In that case, a significant DCF loss was recorded within the first two days (Fig. 2b). The average biodegradation rate was 8.3âμg per day. Against the background of achieving the maximum (13âμg/day) rate of DCF biodegradation, a gradual stable increase in cellular biomass occurred. On day 5, an increase in rhodococcal numbers was accompanied by a significant DCF loss, with its complete decomposition being achieved on day 6 of the experiment.
The obtained data were supported by Rhodococcus respiratory activity measurements, indicative of cell viability and metabolic process intensity (Fig. 3). Cell respiration in the presence of DCF was significantly higher than in controls. The calculated average (18.9âμL/min) rates of O2 consumption during DCF bioconversion were 1.5 times higher than those (12.6âμL/min) in the control (Fig. 3a). The maximum (22.7âμL/min) values of O2 consumption rate in the presence of DCF were registered on experimental day 10. After 10 days, the control exhibited a significant decrease in the O2 uptake rate, while with DCF there was only a slight decline. Cells consumed 15,930âμl of O2 after 14 experimental days, whereas they consumed 12,095âμl of O2 with glucose alone (Fig. 3b). In the abiotic control, respiration values were zero. These data confirm that the DCF decomposition was completely dependent on the cell catalytic activity and catalyzed by oxygenases.
Morphometric changes in rhodococci exposed to different DCF concentrations
The most typical response of rhodococcal cells exposed to DCF was the formation of separate, different-sized, odd-shaped, multi-cellular aggregates in the liquid medium (Fig. 4c,d). The âcooperative cell systemâ seems to ensure the consistent functioning of numerous aggregated cells, allows the population to adapt and grow under âharshâ conditions, in which single cells are not able to replicate and biodegrade this ecotoxicant. The maximum (and more extensive) aggregation was observed in the presence of high (50âmg/L) DCF concentration on day 15 of the experiment (Fig. 4c). Under those conditions, the maximum level of distortion in the morphological cell structure was observed: the changed shape (pleomorphic rods) and enlarged average size of vegetative cells mainly due to swelling (Fig. 5c) and the length change, as well as the increased cell surface area compared to the controls (Table 2). Single cells often suffered the damaged integrity of the peptidoglycan layer accompanied by the release of cytoplasmic components into the medium and accumulation of dead cells in the sample (Fig. 5b). At the morphological level, the destructive DCF effect on R. ruber IEGM 346 was manifested as a decrease (pâ<â0.001) in the surface-to-volume ratio (S/V) of bacterial cells. The reduction in S/V appears to play an important role in bacterial âoppositionâ to toxic effects of the contaminant through reducing the cell surface open to contact with the eco-stressor55. The obtained results support indirectly the toxic DCF effects on rhodococci. Examination of the surface micro-geometry of living IEGM 346 cells did not reveal significant changes either in the root-mean-square roughness values (variations in values did not exceed 9%) or in the amplitude of the microrelief (Table 2), indicating the serious changes in the cell exposed to high DCF concentrations. In the presence of a higher DCF concentration, the cells were severely damaged (Fig. 4c), whereas at a lower concentration, they retained high viability (Fig. 4d).
At lower (50âµg/L) DCF concentrations, the S/V values of bacterial cells evidenced the opposite: under carbon deficiency, the contact area of rhodococci and DCF increased to enhance its absorption and consumption. In that case, a significant increase in the degree of the cell surface roughness was observed (value variations exceeded 60%) (Table 2). We earlier found a similar response of rhodococci exposed to other xenobiotics: organic contaminants56 and resin acids57. At lower DCF concentrations, the number of morphologically heterogeneous cells increased: they were smaller in size, some very significantly; became more oval, often heavily swollen or bean-like, with convex edges (Fig. 4b). Most cells revealed structural crater-like relief (Fig. 5d).
In the presence of DCF, the Rhodococcus culture revealed predominantly cells forming R-type hydrophobic colonies on the agar medium. The colonies were rough, dull, dry, irregularly-edged and odd-shaped, had a pigmented protruding central area and a non-pigmented flat peripheral part. As we have previously shown, cells that form R-type colonies differ from typical S-variants by a thickened rigid cell wall with the double excess of the lipid content58. The R-types are known to exhibit the maximum enzyme concentration in the electron transport chain (cytochromes, flavins), the maximum respiration intensity among dissociants and, ultimately, the maximum growth rate59.
DCF effects on complex physicochemical characteristics of rhodococci (zeta potential, hydrophobicity)
The interaction between DCF and rhodococci resulted in their changed physicochemical characteristics, including the magnitude of Ï-potential, which reflects quantitatively the electro-surface properties of a cell. Cultivation of Rhodococcus cells during the first 10 days at high (50âmg/L) DCF concentration led to a shift in Ï-potential from â35.3â±â2.33 (control) to â31.3â±â0.83âmV (pâ<â0.05), indicating the cationic nature of the ecotoxicant (possibly due to the sodium cation present in the DCF molecule and its interaction with the mycolic acid carboxyl groups of the rhodococcal cell wall) and the electrostatic nature of the initial DCF interaction with bacterial cells. On exposure days 20 and 30, a successive shift of Ï-potential toward the negative values â37.5â±â2.33 and â47.8â±â2.57, respectively, was registered. It should be noted that the longer was the cell exposure to DCF, the more negatively charged they became. During this period, a significant number of involutional and lysing cell forms were observed.
Cells grown at low (50âμg/L) DCF concentrations did not statistically differ in Ï-potential from those cultivated at high DCF concentrations: the numerical values were in similar Ï-potential range. Negative values of the bacterial cell potential are a consequence of the total negatively charged molecules of lipids, lipoglycans, teichoic and lipoteichoic acids in the bacterial cell wall60. Unlike other Gram-positive bacteria, the Rhodococcus cell wall has an unusual structure and composition. It is dominated by complex specific lipids composed of 2-alkyl 3-hydroxy branched-chain fatty acids accounting for the formation of an external impermeable lipid barrier61. According to our data, the amount of rhodococci-synthesized lipids varied depending on the medium composition. The presence of DCF induced a considerable (almost 2-fold) increase in total lipid content in rhodococci (70.8â±â4.46% of ADW) compared to that of LB broth-grown cells (43.4â±â1.72% of ADW). The growth in the lipid component of DCF-cultured rhodococci apparently helps maintain the integrity of the cell membrane and enhances its stability. The data obtained indicate that in the course of DCF biodegradation, the structure of the developing Rhodococcus population changed smoothly toward the forms more resistant to toxic DCF effects.
As the Ï-zeta potential shift occurred during DCF biodegradation, an intensive formation of cell aggregates was observed. This was consistent with the literature data62 that the decrease in the numerical Ï-potential values of Gram-positive bacteria boosts the cell aggregation phenomenon. The bacterial aggregate formation is not only due to DCF properties and the bacterial surface composition, but also due to the degree of cell surface hydrophobicity. The salt aggregation test showed the hydrophobic interactions between cells to be enhanced in the presence of DCF, which promoted the development of cell aggregates. This is illustrated in Fig. 6: rhodococci produced stable microaggregates when exposed to a relatively low (0.6âM) ammonium sulfate concentration, indicating significant hydrophobicity of their cell surface (Fig. 6b2). It should be noted that at different initial DCF concentrations, a clear tendency (more pronounced at higher DCF concentrations) to cell agglomeration was observed in rhodococci, namely to the growth as discrete, distributed across the liquid mineral medium and visually observed bioconglomerates (globules) of different size and consistency. The obtained results are in agreement with the data of Bouchez-Naïtali et al.63 reported on high hydrophobicity of flocculating rhodococci grown on hydrophobic substrates and the ability of highly hydrophobic cells to self-aggregate. Such aggregates of hydrophobic cells seem to contribute to cooperative effects of oxidative enzymes on the ecotoxicant.
Proposed pathways for DCF biodegradation
According to TLC and GC-MS results, bacterial degradation of DCF was accompanied by formation of metabolites. Figure 7 presents a possible scheme for 2-[2-(2â²,6â²-dichloroanilino)phenyl]acetate sodium salt (1) decomposition by R. ruber IEGM 346. During the first 5â10 days of incubation of rhodococci with high (50âmg/L) DCF concentrations, the primary DCF monohydroxy metabolites 2-[2-(2â²,6â²-dichloro-4â²-hydroxyanilino)phenyl]acetic acid (4â²-OH-DCF, 3), 2-[2-2â²,6â²-dichloroanilino)-5-hydroxyphenyl]acetic acid (5-OH-DCF, 4), and also 5 of the benzoquinonimine-type and its dihydroxy derivative (16) were detected among DCF (2) biodegradation products (Supplementary Figs S1âS3). Afterwards, 2,6-dichloroaniline mono- and dihydroxy derivatives (6 and 8) were found in the incubation medium resulting from the C-N bond cleavage at the second carbon atom of the non-chlorinated aromatic ring of compounds 3 and 4. Additionally, phenylacetic acid (7) and its hydroxylated derivative 3-hydroxyphenylacetic acid (9) were detected (Supplementary Fig. S4).
At lower (50âμg/L) DCF concentration, the above products were detected in the first 2 days of Rhodococcus incubation. On day 4, metabolites spectroscopically similar to a homogentisinic (2,5-dihydroxyphenylacetic) acid, m/z 168 (10) and its oxidation product 2-(p-benzoquinone-2)acetic acid, m/z 166 (11), and also similar to a fumarylacetoacetic acid, m/z 200 (12) and its hydrolysis products acetoacetic acid, m/z 102, and fumaric acid, m/z 116 (13 and 14, respectively), were recorded in the medium (Supplementary Figs S5âS7). The presence of phenylacetic acid (Rf 0.64) in the intermediate stage of DCF biodegradation, and fumaric acid (Rf 0.83) at the end of DCF biodegradation was confirmed by TLC results (Supplementary Table S1).
Additionally, an intense peak of 15 (m/z 214) was observed; this compound apparently resulted from the oxidation of 12 at the seventh carbon atom due to the mobile hydrogen atoms between the carboxyl and ketone groups (Supplementary Fig. S7). The presence of the ketone group and the double bond was confirmed using semicarbazide hydrochloride and bromine water. In the IR spectra of dry residues of DCF metabolites, the characteristic absorption bands of phenol hydroxyl at 3,400âcmâ1 at the beginning of the experiment and ketone carbonyl at 1,670â1,680âcmâ1 at the end of the experiment were observed. At the end of fermentation (on experimental day 6), DCF and the above compounds were not detected in the incubation medium of rhodococci, indicating the further metabolite transformation. The controls showed no DCF metabolites.
Discussion
Screening of 104 Rhodococcus strains from the IEGM collection resulted in selection of R. ruber IEGM 346 highly tolerant (MIC 200âmg/L) to DCF. Within 6 days, this strain completed the ecotoxic DCF (50âμg/L) degradation with glucose (0.5%) added to ensure significant cell growth, and rhodococci pre-incubation at low (5âμg/L) DCF concentration to stimulate the multipurpose oxygenase complex.
DCF exposure on rhodococci was shown to lead to morphological anomalies of cells manifested in the changed cell shape and size, and surface roughness. In the presence of DCF, there was a significant cell aggregation, as well as a change in ζ-potential, an increase in hydrophobicity and total cellular lipid content.
Knowledge on the ecopollutant metabolism is an important factor in assessing its safety. With glucose added, rhodococci decompose DCF via three proposed pathways for primary hydroxy metabolites (Fig. 7). Pathway I: 4â²-ÐÐ-DCF (3) decomposes due to C-N bond cleavage at the second carbon atom in the non-chlorinated aromatic ring to form 4-amino-3,5-dichlorophenol (6) and phenylacetic acid (7). The latter is hydroxylated at positions 2 and 5 of the aromatic ring to homogentisinic (2,5-dihydroxyphenylacetic) acid (10), which is oxidized to 2-(p-benzoquinone-2)acetic acid (11). Subsequent oxidation of 11 leads to the quinone ring cleavage at positions 5 and 6 to form fumarylacetoacetic acid (12), which is hydrolyzed to form acetoacetic acid (13) and fumaric acid (14). Pathway II: 5-ÐÐ-DCF (4) is decomposed owing to C-N bond cleavage at the second carbon atom in the non-chlorinated aromatic ring to form 5-amino-4,6-dichlorobenzene-1,2-diol (8) and 3-hydroxyphenylacetic acid (9). Compound 9 is oxidized to form homogentisinic acid (10), which is further converted to 2-(p-benzoquinone-2)acetic acid (11). Subsequent transformations of 11 via the pathway I lead to acetoacetic acid (13) and fumaric acid (14). Pathway III: 5-OH-DCF (4) is oxidized to form benzoquinonimine (5), which is hydroxylated to form a dihydroxy compound (16). The azomethine bond in 16 is hydrolyzed to form 8 and quinone (11), with concurrent structure oxidation at the second carbon atom. Compound 11 undergoes the above changes via pathway I.
Particularly noteworthy are two events: (i) the CâN bond cleavage in DCF structure to form phenylacetic acid, and (ii) the possible quinone ring opening to form fumarylacetoacetic acid and its hydrolysis products acetoacetic and fumaric acids, which can be considered as DCF detoxification products. Further research is needed to confirm these findings.
In this study, 16 metabolites produced by R. ruber IEGM 346 were identified, four of which (4â²-OH-DCF, 5-OH-DCF and two benzoquinone imine-type compounds) are similar to those obtained in earlier studies of DCF metabolism by the alphaproteobacterium Labrys portucalensis F1145, and two metabolites (4â²-OH-DCF and 5-OH-DCF) obtained using Gram-positive bacteria Actinoplanes40. However, all the above metabolites retained the C-N bond at the second carbon atom in the non-chlorinated aromatic ring of DCF. At the same time, there was no evidence confirming the aromatic ring opening in the structures of compounds formed.
The obtained fundamental data elucidate the ecological role of rhodococci in detoxification of pharma pollutants and underpin the implementation of innovative technical solutions for advanced pharmaceutical sewage treatment. Because R. ruber IEGM 346 converts DCF to form lots of metabolites that are relatively easy to detect, isolate and identify, and also shows similarity to DCF metabolism in mammals, this strain can be used as a bacterial model, alternative to mammalian model systems64, to study the metabolism of polycyclic aromatic pharmaceutical compounds and their metabolitesâ synthesis. Additionally, rhodococci have a high level of expression of P450s (CYPs), enzymes2 involved in drug metabolism by changing the functional groups of the parent molecule.
Data Availability
The data generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
de Carvalho, C. C. C. R. Adaptation of Rhodococcus to organic solvents. In Biology of Rhodococcus (ed. Alvarez, H. M.) 109â131 (Springer-Verlag, 2010).
Ivshina, I. B., Kuyukina, M. S. & Krivoruchko, A. V. Hydrocarbon-oxidizing bacteria and their potential in eco-biotechnology and bioremediation. In Microbial Resources (ed. Kurtböke, I.) 121â148 (Elsevier Inc., 2017).
Kuyukina, M. S. & Ivshina, I. B. Application of Rhodococcus in bioremediation of contaminated environments. In Biology of Rhodococcus (ed. Alvarez, H. M.) 231â262 (Springer-Verlag, 2010).
Larkin, M. J., Kulakov, L. A. & Allen, C. C. R. Biodegradation by members of the genus Rhodococcus: biochemistry, physiology, and genetic adaptation. Adv. Appl. Microbiol. 59, 1â29 (2006).
Gauthier, H., Yargeau, V. & Cooper, D. G. Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism. Sci. Total Environ. 408, 1701â1706 (2010).
Evangelista, S., Yargeau, V. & Cooper, D. G. The recalcitrance of clofibric acid to microbial degradation. WIT Trans. Ecol. Environ. 111, 273â278 (2008).
Kim, Y. U. et al. Steroid 9α-hydroxylation during testosterone degradation by resting Rhodococcus equi cells. Arch. Pharm. (Weinheim). 340, 209â214 (2007).
Larcher, S. & Yargeau, V. Biodegradation of 17α-ethinylestradiol by heterotrophic bacteria. Environ. Pollut. 173, 17â22 (2013).
OâGrady, D., Evangelista, S. & Yargeau, V. Removal of aqueous 17α-ethinylestradiol by Rhodococcus species. Environ. Eng. Sci. 26, 1393â1400 (2009).
Yoshimoto, T. et al. Degradation of estrogens by Rhodococcus zopfii and Rhodococcus equi isolates. Appl. Environ. Microbiol. 70, 5283â5289 (2004).
Ivshina, I. B., Rychkova, M. I., Vikhareva, E. V., Chekryshkina, L. A. & Mishenina, I. I. Catalysis of the biodegradation of unusable medicines by alkanotrophic rhodococci. Appl. Biochem. Microbiol. 42, 392â395 (2006).
Ivshina, I. B., Vikhareva, E. V., Richkova, M. I., Mukhutdinova, A. N. & Karpenko, J. N. Biodegradation of drotaverine hydrochloride by free and immobilized cells of Rhodococcus rhodochrous IEGM 608. World J. Microbiol. Biotechnol. 28, 2997â3006 (2012).
Ivshina, I. B. et al. Drotaverine hydrochloride degradation using cyst-like dormant cells of Rhodococcus ruber. Curr. Microbiol. 70, 307â314 (2014).
aus der Beek, T. et al. Pharmaceuticals in the environment â global occurrences and perspectives. Environ. Toxicol. Chem. 35, 823â835 (2016).
Fatta-Kassinos, D., Meric, S. & Nikolaou, A. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal. Bioanal. Chem. 399, 251â275 (2011).
Zhang, Y., GeiÃen, S. U. & Gal, C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73, 1151â1161 (2008).
Sui, Q. et al. Occurrence, sources and fate of pharmaceuticals and personal care products in the groundwater: a review. Emerg. Contam. 1, 14â24 (2015).
Yang, L. et al. Occurrence, distribution, and attenuation of pharmaceuticals and personal care products in the riverside groundwater of the Beiyun River of Beijing, China. Environ. Sci. Pollut. Res. 24, 15838â15851 (2017).
Alygizakis, N. A. et al. Occurrence and spatial distribution of 158 pharmaceuticals, drugs of abuse and related metabolites in offshore seawater. Sci. Total Environ. 541, 1097â1105 (2016).
Huebner, M., Weber, E., Niessner, R., Boujday, S. & Knopp, D. Rapid analysis of diclofenac in freshwater and wastewater by a monoclonal antibody-based highly sensitive ELISA. Anal. Bioanal. Chem. 407, 8873â8882 (2015).
Nebot, C., Falcon, R., Boyd, K. G. & Gibb, S. W. Introduction of human pharmaceuticals from wastewater treatment plants into the aquatic environment: a rural perspective. Environ. Sci. Pollut. Res. 22, 10559â10568 (2015).
UNESCO and HELCOM. Pharmaceuticals in the aquatic environment of the Baltic Sea region. (UNESCO Publishing, 2017).
Dasenaki, M. E. & Thomaidis, N. S. Multianalyte method for the determination of pharmaceuticals in wastewater samples using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 407, 4229â4245 (2015).
Kot-Wasik, A., Jakimska, A. & Åliwka-KaszyÅska, M. Occurrence and seasonal variations of 25 pharmaceutical residues in wastewater and drinking water treatment plants. Environ. Monit. Assess. 188, 661, https://doi.org/10.1007/s10661-016-5637-0 (2016).
Rivera-Jaimes, J. A. et al. Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: occurrence and environmental risk assessment. Sci. Total Environ. 613â614, 1263â1274 (2018).
Singh, K. P., Rai, P., Singh, A. K., Verma, P. & Gupta, S. Occurrence of pharmaceuticals in urban wastewater of north Indian cities and risk assessment. Environ. Monit. Assess. 186, 6663â6682 (2014).
Vieno, N. & Sillanpää, M. Fate of diclofenac in municipal wastewater treatment plant â a review. Environ. Int. 69, 28â39 (2014).
Khan, U. & Nicell, J. Human health relevance of pharmaceutically active compounds in drinking water. AAPS J. 17, 558â585 (2015).
Simazaki, D. et al. Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health. Water Res. 76, 187â200 (2015).
Bouju, H. et al. Elucidation of biotransformation of diclofenac and 4â²hydroxydiclofenac during biological wastewater treatment. J. Hazard. Mater. 301, 443â452 (2016).
Gröning, J. et al. Transformation of diclofenac by the indigenous microflora of river sediments and identification of a major intermediate. Chemosphere 69, 509â516 (2007).
Barra Caracciolo, A., Topp, E. & Grenni, P. Pharmaceuticals in the environment: biodegradati on and effects on natural microbial communities. A review. J. Pharm. Biomed. Anal. 106, 25â36 (2015).
González-Alonso, S. et al. Occurrence of pharmaceutical, recreational and psychotropic drug residues in surface water on the northern Antarctic Peninsula region. Environ. Pollut. 229, 241â254 (2017).
Acuña, V. et al. Balancing the health benefits and environmental risks of pharmaceuticals: diclofenac as an example. Environ. Int. 85, 327â333 (2015).
D. 495/2015/EU. Commission Implementig Decision (EU) 2015/495 of 20 March 2015 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council. Off. J. Eur. Union. 78, 40â42 (2015).
Fischer, K., Kühnert, M., Gläser, R. & Schulze, A. Photocatalytic degradation and toxicity evaluation of diclofenac by nanotubular titanium dioxide-PES membrane in a static and continuous setup. RSC Adv. 5, 16340â16348 (2015).
Márquez Brazón, E., Piccirillo, C., Moreira, I. S. & Castro, P. M. L. Photodegradation of pharmaceutical persistent pollutants using hydroxyapatite-based materials. J. Environ. Manage. 182, 486â495 (2016).
Schröder, P. et al. Status of hormones and painkillers in wastewater effluents across several European states â considerations for the EU watch list concerning estradiols and diclofenac. Environ. Sci. Pollut. Res. 23, 12835â12866 (2016).
Domaradzka, D., Guzik, U. & WojcieszyÅska, D. Biodegradation and biotransformation of polycyclic non-steroidal anti-inflammatory drugs. Rev. Environ. Sci. Biotechnol. 14, 229â239 (2015).
Osorio-Lozada, A., Surapaneni, S., Skiles, G. L. & Subramanian, R. Biosynthesis of drug metabolites using microbes in hollow fiber cartridge reactors: case study of diclofenac metabolism by Actinoplanes species. Drug Metab. Dispos. 36, 234â240 (2008).
Bessa, V. S., Moreira, I. S., Tiritan, M. E. & Castro, P. M. L. Enrichment of bacterial strains for the biodegradation of diclofenac and carbamazepine from activated sludge. Int. Biodeterior. Biodegrad. 120, 135â142 (2017).
Kosjek, T., Heath, E., Pérez, S., PetroviÄ, M. & Barceló, D. Metabolism studies of diclofenac and clofibric acid in activated sludge bioreactors using liquid chromatography with quadrupole-time-of-flight mass spectrometry. J. Hydrol. 372, 109â117 (2009).
Langenhoff, A. et al. Microbial removal of the pharmaceutical compounds ibuprofen and diclofenac from wastewater. Biomed Res. Int. 2013, 325806, https://doi.org/10.1155/2013/325806 (2013).
Tiehm, A. et al. Biodegradation of pharmaceutical compounds and their occurrence in the Jordan valley. Water Resour. Manag. 25, 1195â1203 (2011).
Moreira, I. S. et al. Biodegradation of diclofenac by the bacterial strain Labrys portucalensis F11. Ecotoxicol. Environ. Saf. 152, 104â113 (2018).
Aissaoui, S., Ouled-Haddar, H., Sifour, M., Harrouche, K. & Sghaier, H. Metabolic and co-metabolic transformation of diclofenac by Enterobacter hormaechei D15 isolated from activated sludge. Curr. Microbiol. 74, 381â388 (2017).
Stylianou, K., Hapeshi, E., Vasquez, M. I., Fatta-Kassinos, D. & Vyrides, I. Diclofenac biodegradation by newly isolated Klebsiella sp. KSC: microbial intermediates and ecotoxicological assessment. J. Environ. Chem. Eng. 6, 3242â3248 (2018).
Catalogue of Strains of Regional Specialised Collection of Alkanotrophic Microorganisms. Available at, http://www.iegmcol.ru/strains/index.html.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 27th ed. CLSI. (Wayne, PA, 2017).
Lindahl, M., Faris, A., Wadström, T. & Hjertén, S. A new test based on âsalting outâ to measure relative hydrophobicity of bacterial cells. BBA â Gen. Subj. 677, 471â476 (1981).
Mattos-Guaraldi, A. L., Formiga, L. C. D. & Andrade, A. F. B. Cell surface hydrophobicity of sucrose fermenting and nonfermenting Corynebacterium diphtheriae strains evaluated by different methods. Curr. Microbiol. 38, 37â42 (1999).
Dastidar, S. G., Ganguly, K., Chaudhuri, K. & Chakrabarty, A. N. The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int. J. Antimicrob. Agents 14, 249â251 (2000).
Salem-Milani, A. et al. Antibacterial effect of diclofenac sodium on Enterococcus faecalis. J. Dent. (Tehran) 10, 16â22 (2013).
Dutta, N. K. et al. Antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin. Brazilian J. Microbiol. 35, 316â323 (2004).
Neumann, G. et al. Cells of Pseudomonas putida and Enterobacter sp. adapt to toxic organic compounds by increasing their size. Extremophiles 9, 163â168 (2005).
Korshunova, I. O., Pistsova, O. N., Kuyukina, M. S. & Ivshina, I. B. The effect of organic solvents on the viability and morphofunctional properties of Rhodococcus. Appl. Biochem. Microbiol. 52, 43â50 (2016).
Cheremnykh, K. M., Luchnikova, N. A., Grishko, V. V. & Ivshina, I. B. Bioconversion of ecotoxic dehydroabietic acid using Rhodococcus actinobacteria. J. Hazard. Mater. 346, 103â112 (2018).
Kuyukina, M. S., Ivshina, I. B., Rychkova, M. I. & Chumakov, O. B. Effect of cell lipid composition on the formation of nonspecific antibiotic resistance in alkanotrophic rhodococci. Microbiology 69, 51â57 (2000).
Iwabuchi, N., Sunairi, M., Anzai, H., Nakajima, M. & Harayama, S. Relationships between colony morphotypes and oil tolerance in Rhodococcus rhodochrous. Appl. Environ. Microbiol. 66, 5073â5077 (2000).
Wilson, W. W., Wade, M. M., Holman, S. C. & Champlin, F. R. Status of methods for assessing bacterial cell surface charge. J. Microbiol. Methods 43, 153â164 (2001).
Gibson, K. J. C. et al. Structural and functional features of Rhodococcus ruber lipoarabinomannan. Microbiology 149, 1437â1445 (2003).
KÅodziÅska, E. et al. Effect of zeta potential value on bacterial behavior during electrophoretic separation. Electrophoresis 31, 1590â1596 (2010).
Bouchez-Naïtali, M., Blanchet, D., Bardin, V. & Vandecasteele, J. P. Evidence for interfacial uptake in hexadecane degradation by Rhodococcus equi: the importance of cell flocculation. Microbiology 147, 2537â2543 (2001).
Asha, S. & Vidyavathi, M. Cunninghamella â a microbial model for drug metabolism studies â a review. Biotechnol. Adv. 27, 16â29 (2009).
Acknowledgements
This work was fulfilled under the State assignment (01201353247) and supported by the grant of the Russian Foundation for basic Research and the Ministry of Education and Science of Perm Krai (17-44-590567).
Author information
Authors and Affiliations
Contributions
I.B.I. proposed the research concept, analyzed and interpreted the data and contributed substantially to the writing and reviewing of the manuscript. E.A.T. designed and performed the experiments, contributed to the writing of the manuscript. M.V.K. performed identification of DCF metabolites by GC-MS. E.V.V. interpreted GC-MS data, proposed DCF biodegradation pathways. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisherâs note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the articleâs Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the articleâs Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ivshina, I.B., Tyumina, E.A., Kuzmina, M.V. et al. Features of diclofenac biodegradation by Rhodococcus ruber IEGM 346. Sci Rep 9, 9159 (2019). https://doi.org/10.1038/s41598-019-45732-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-45732-9
This article is cited by
-
Performance of pharmaceutical products removal in a bioelectrochemical system at low temperatures and changes in microbial communities and antibiotic resistance genes
Environmental Science and Pollution Research (2024)
-
Selective enrichment, identification, and isolation of diclofenac, ibuprofen, and carbamazepine degrading bacteria from a groundwater biofilm
Environmental Science and Pollution Research (2023)
-
Both biogenic and chemically synthesized metal sulfide nanoparticles induce oxidative stress and enhance lipid accumulation in Rhodococcus opacus
BioMetals (2023)
-
Characteristics and growth kinetics of biomass of Citrobacter freundii strains PYI-2 and Citrobacter portucalensis strain YPI-2 during the biodegradation of Ibuprofen
International Microbiology (2022)
-
Metabolism of the aquatic pollutant diclofenac in the Lymnaea stagnalis freshwater gastropod
Environmental Science and Pollution Research (2022)